Home - Products - Autophagy - Autophagy - Sulfacetamide sodium salt hydrate

Sulfacetamide sodium salt hydrate

CAS No. 6209-17-2

Sulfacetamide sodium salt hydrate ( —— )

Catalog No. M15350 CAS No. 6209-17-2

Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 27 In Stock
100MG 47 In Stock
200MG 77 In Stock
500MG 128 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sulfacetamide sodium salt hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
  • Description
    Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    DHPS
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    6209-17-2
  • Formula Weight
    254.20
  • Molecular Formula
    C8H9N2NaO3S·H2O
  • Purity
    >98%(HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O.[Na].CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hevener KE, et al. J Chem Inf Model. 2009 Jan 27.
molnova catalog
related products
  • LY2183240

    LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).

  • Proguanil hydrochlor...

    Proguanil Hydrochloride is a biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent.

  • SMER-18

    A small molecule autophagy enhancer that induces autophagy independently of rapamycin in mammalian cells and enhances the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein; reduces toxicity in Huntington's disease models.